tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DAWN Stock Latest News

Day One Biopharmaceuticals Approves Key Proposals at Annual Meeting
Company AnnouncementsDay One Biopharmaceuticals Approves Key Proposals at Annual Meeting
4d ago
8K
DAWN
Positive Outlook for Day One Biopharmaceuticals’ Ojemda: A Promising First-Line Treatment for Pediatric Glioma
PremiumRatings
Positive Outlook for Day One Biopharmaceuticals’ Ojemda: A Promising First-Line Treatment for Pediatric Glioma
5d ago
DAWN
Buy Rating for Day One Biopharmaceuticals Driven by FDA Approval and Strong Market Potential
PremiumRatings
Buy Rating for Day One Biopharmaceuticals Driven by FDA Approval and Strong Market Potential
5d ago
DAWN
Promising Future for Day One Biopharmaceuticals: Buy Rating on Ojemda’s Potential in Pediatric Brain Tumors
PremiumRatings
Promising Future for Day One Biopharmaceuticals: Buy Rating on Ojemda’s Potential in Pediatric Brain Tumors
6d ago
DAWN
Day One Biopharma’s Earnings Call Highlights Growth
PremiumCompany Announcements
Day One Biopharma’s Earnings Call Highlights Growth
1M ago
DAWN
Day One price target lowered to $26 from $30 at JonesResearch
PremiumThe FlyDay One price target lowered to $26 from $30 at JonesResearch
1M ago
DAWN
Day One Biopharmaceuticals: A Compelling Buy Amidst Growth Potential and Strong Financial Position
Premium
Ratings
Day One Biopharmaceuticals: A Compelling Buy Amidst Growth Potential and Strong Financial Position
1M ago
DAWN
Positive Outlook for Day One Biopharmaceuticals Despite Seasonal Challenges, Buy Rating Reaffirmed
Premium
Ratings
Positive Outlook for Day One Biopharmaceuticals Despite Seasonal Challenges, Buy Rating Reaffirmed
1M ago
DAWN
Optimistic Outlook for Day One Biopharmaceuticals: Buy Rating Affirmed Amid Promising Ojemda Launch and Growth Potential
PremiumRatings
Optimistic Outlook for Day One Biopharmaceuticals: Buy Rating Affirmed Amid Promising Ojemda Launch and Growth Potential
1M ago
DAWN
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising Growth and Strategic Advancements
PremiumRatings
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising Growth and Strategic Advancements
1M ago
DAWN
Day One Biopharmaceuticals Reports Strong Q1 2025 Results
PremiumCompany Announcements
Day One Biopharmaceuticals Reports Strong Q1 2025 Results
1M ago
DAWN
Positive Growth Outlook for Day One Biopharmaceuticals Driven by Strong Q1 Performance and Strategic Initiatives
PremiumRatings
Positive Growth Outlook for Day One Biopharmaceuticals Driven by Strong Q1 Performance and Strategic Initiatives
1M ago
DAWN
Day One Biopharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsDay One Biopharmaceuticals Reports Q1 2025 Financial Results
1M ago
8K
DAWN
Day One Biopharmaceuticals reports Q1 EPS (35c), consensus (44c)
Premium
The Fly
Day One Biopharmaceuticals reports Q1 EPS (35c), consensus (44c)
1M ago
DAWN
DAWN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
DAWN Upcoming Earnings Report: What to Expect?
1M ago
DAWN
Day One Biopharmaceuticals price target lowered to $21 from $24 at BofA
PremiumThe Fly
Day One Biopharmaceuticals price target lowered to $21 from $24 at BofA
2M ago
DAWN
Promising Outlook for Day One Biopharmaceuticals: Buy Rating Driven by Ojemda’s Market Potential
PremiumRatings
Promising Outlook for Day One Biopharmaceuticals: Buy Rating Driven by Ojemda’s Market Potential
2M ago
DAWN
Buy Rating for Day One Biopharmaceuticals: Strong Financial Position and Strategic Growth Potential
PremiumRatings
Buy Rating for Day One Biopharmaceuticals: Strong Financial Position and Strategic Growth Potential
3M ago
DAWN
Day One Biopharmaceuticals price target lowered to $34 from $39 at JPMorgan
PremiumThe Fly
Day One Biopharmaceuticals price target lowered to $34 from $39 at JPMorgan
3M ago
DAWN
Day One Biopharma’s Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsDay One Biopharma’s Earnings Call Highlights Growth and Challenges
3M ago
DAWN
Day One price target lowered to $30 from $34 at JonesResearch
Premium
The Fly
Day One price target lowered to $30 from $34 at JonesResearch
3M ago
DAWN
Buy Rating on Day One Biopharmaceuticals: Strong Performance and Promising Future Prospects
Premium
Ratings
Buy Rating on Day One Biopharmaceuticals: Strong Performance and Promising Future Prospects
3M ago
DAWN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >